Madrigal Pharmaceuticals ROA 2007-2018 | MDGL

Current and historical return on assets (ROA) values for Madrigal Pharmaceuticals (MDGL) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Madrigal Pharmaceuticals ROA for the three months ending September 30, 2018 was -8.78%.
Madrigal Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.03B $0.49B -8.55%
2018-06-30 $-0.03B $0.49B -12.04%
2018-03-31 $-0.03B $0.18B -23.72%
2017-12-31 $-0.03B $0.19B -33.06%
2017-09-30 $-0.03B $0.06B -56.60%
2017-06-30 $-0.04B $0.07B -75.39%
2017-03-31 $-0.03B $0.04B -73.81%
2016-12-31 $-0.03B $0.04B -59.67%
2016-09-30 $0.02B $0.04B 45.71%
2016-06-30 $0.03B $0.05B 59.26%
2016-03-31 $0.01B $0.05B 17.89%
2015-12-31 $-0.01B $0.00B -11.76%
2015-09-30 $-0.06B $0.09B -67.56%
2015-06-30 $-0.08B $0.10B -79.80%
2015-03-31 $-0.08B $0.08B -79.05%
2014-12-31 $-0.09B $0.10B -81.32%
2014-09-30 $-0.09B $0.12B -86.33%
2014-06-30 $-0.09B $0.12B -106.29%
2014-03-31 $-0.09B $0.08B -122.08%
2013-12-31 $-0.09B $0.10B -113.75%
2013-09-30 $-0.09B $0.06B -103.66%
2013-06-30 $-0.08B $0.07B -93.62%
2013-03-31 $-0.07B $0.09B -91.39%
2012-12-31 $-0.06B $0.10B -94.03%
2012-09-30 $-0.06B $0.06B -108.21%
2012-06-30 $-0.05B $0.05B -106.40%
2012-03-31 $-0.05B $0.06B -93.69%
2011-12-31 $-0.05B $0.04B -93.66%
2011-09-30 $-0.05B $0.05B -84.79%
2011-06-30 $-0.04B $0.07B -77.83%
2011-03-31 $-0.04B $0.04B -75.00%
2010-12-31 $-0.04B $0.05B -64.91%
2010-09-30 $-0.04B $0.06B -62.78%
2010-06-30 $0.09B $0.05B 166.82%
2010-03-31 $0.09B $0.06B 157.98%
2009-12-31 $0.08B $0.05B 119.85%
2009-09-30 $0.06B $0.06B 77.46%
2009-06-30 $-0.08B $0.07B -95.40%
2009-03-31 $-0.10B $0.09B -106.81%
2008-12-31 $-0.09B $0.10B -97.38%
2008-09-30 $-0.08B $0.09B -81.37%
2008-06-30 $-0.07B $0.09B -77.21%
2008-03-31 $-0.07B $0.11B -73.74%
2007-12-31 $-0.12B $0.12B -146.43%
2007-09-30 $-0.12B $0.06B -179.10%
2007-06-30 $-0.12B $0.07B -226.42%
2007-03-31 $-0.12B $0.09B -337.14%
2006-12-31 $-0.06B $0.06B -429.09%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.697B $0.000B
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $53.409B 11.39
Zoetis (ZTS) United States $42.496B 29.09
Grifols (GRFS) Spain $12.892B 15.73
Jazz Pharmaceuticals (JAZZ) Ireland $8.479B 12.17
Ionis Pharmaceuticals (IONS) United States $7.282B 0.00
Tilray (TLRY) United States $6.999B 0.00
Neurocrine Biosciences (NBIX) United States $6.469B 1426.80
Nektar Therapeutics (NKTR) United States $6.319B 9.06
Catalent (CTLT) United States $5.036B 21.12
Impax Laboratories (AMRX) United States $4.810B 0.00
Sage Therapeutics (SAGE) United States $4.782B 0.00
United Therapeutics (UTHR) United States $4.703B 7.69
Loxo Oncology (LOXO) United States $4.251B 0.00
TESARO (TSRO) United States $4.056B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.483B 12.90
FibroGen (FGEN) United States $3.361B 0.00
USANA Health Sciences (USNA) United States $2.895B 24.64
Endo (ENDP) Ireland $2.286B 3.50
Xencor (XNCR) United States $2.031B 0.00
Endocyte (ECYT) United States $1.957B 0.00
Heron Therapeutics (HRTX) United States $1.948B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.861B 251.44
Corcept Therapeutics (CORT) United States $1.860B 27.31
Ironwood Pharmaceuticals (IRWD) United States $1.810B 0.00
Zogenix (ZGNX) United States $1.739B 0.00
Aerie Pharmaceuticals (AERI) United States $1.737B 0.00
PTC Therapeutics (PTCT) United States $1.697B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.463B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.433B 20.15
Tricida (TCDA) United States $1.340B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.321B 0.00
Esperion Therapeutics (ESPR) United States $1.286B 0.00
Portola Pharmaceuticals (PTLA) United States $1.252B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.238B 0.00
TherapeuticsMD (TXMD) United States $0.921B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.906B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.807B 0.00
ImmunoGen (IMGN) United States $0.772B 0.00
Radius Health (RDUS) United States $0.719B 0.00
Forty Seven (FTSV) United States $0.712B 0.00
Collegium Pharmaceutical (COLL) United States $0.603B 0.00
Karyopharm Therapeutics (KPTI) United States $0.584B 0.00
Siga Technologies (SIGA) United States $0.558B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.513B 0.00
ChemoCentryx (CCXI) United States $0.507B 40.12
Flexion Therapeutics (FLXN) United States $0.505B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.446B 26.29
GlycoMimetics (GLYC) United States $0.446B 0.00
Akebia Therapeutics (AKBA) United States $0.435B 0.00
Xeris Pharmaceuticals (XERS) United States $0.420B 0.00
Dova Pharmaceuticals (DOVA) United States $0.418B 0.00
Dermira (DERM) United States $0.417B 0.00
Odonate Therapeutics (ODT) United States $0.406B 0.00
CASI Pharmaceuticals (CASI) United States $0.405B 0.00
Tyme Technologies (TYME) United States $0.398B 0.00
KalVista Pharmaceuticals (KALV) United States $0.390B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Translate Bio (TBIO) United States $0.370B 0.00
ArQule (ARQL) United States $0.351B 0.00
OptiNose (OPTN) United States $0.340B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.336B 0.00
Majesco Entertainment (PTE) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.316B 0.00
Tapimmune (MRKR) United States $0.309B 0.00
Minerva Neurosciences (NERV) United States $0.305B 0.00
Aclaris Therapeutics (ACRS) United States $0.299B 0.00
Aratana Therapeutics (PETX) United States $0.299B 0.00
Mast Therapeutics (SVRA) United States $0.261B 0.00
Depomed (ASRT) United States $0.259B 9.64
Verrica Pharmaceuticals (VRCA) United States $0.258B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
IMV INC (IMV) Canada $0.245B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.240B 0.00
Ocular Therapeutix (OCUL) United States $0.219B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Affimed (AFMD) Germany $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.205B 0.00
Zafgen (ZFGN) United States $0.191B 0.00
Lannett Co Inc (LCI) United States $0.190B 1.65
TAIWAN LIPOSOME (TLC) Taiwan $0.188B 0.00
Aquestive Therapeutics (AQST) United States $0.184B 0.00
MEI Pharma (MEIP) United States $0.180B 0.00
Calithera Biosciences (CALA) United States $0.175B 0.00
Opexa Therapeutics (ACER) United States $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.172B 0.00
Molecular Templates (MTEM) United States $0.166B 0.00
ContraFect (CFRX) United States $0.165B 0.00
Recro Pharma (REPH) United States $0.164B 0.00
Nature's Sunshine Products (NATR) United States $0.162B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.159B 0.00
Neon Therapeutics (NTGN) United States $0.158B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.147B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.145B 0.00
Redhill Biopharma (RDHL) Israel $0.145B 0.00
Ardelyx (ARDX) United States $0.134B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.133B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.132B 0.00
MediWound (MDWD) Israel $0.130B 0.00
Cardiome Pharma (CORV) Canada $0.129B 0.00
ElectroCore (ECOR) United States $0.120B 0.00
Adherex Technologies (FENC) United States $0.117B 0.00
Jounce Therapeutics (JNCE) United States $0.115B 0.00
DURECT (DRRX) United States $0.112B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
ProNAi Therapeutics (SRRA) Canada $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.102B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.081B 0.00
Immune Design (IMDZ) United States $0.076B 0.00
Achaogen (AKAO) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.075B 7.36
CTI BioPharma (CTIC) United States $0.072B 0.00
Otonomy (OTIC) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Melinta Therapeutics (MLNT) United States $0.066B 0.00
BioLineRx (BLRX) Israel $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.062B 0.00
KemPharm (KMPH) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.056B 0.00
Genocea Biosciences (GNCA) United States $0.048B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
ProPhase Labs (PRPH) United States $0.036B 0.00
Capnia (SLNO) United States $0.035B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
Novan (NOVN) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.030B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Trillium Therapeutics (TRIL) Canada $0.027B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.020B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.020B 0.00
Citius Pharmaceuticals (CTXR) United States $0.020B 0.00
PharmAthene (ALT) United States $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Onconova Therapeutics (ONTX) United States $0.018B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.05
ESSA Pharma (EPIX) Canada $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.014B 0.00
Shineco (TYHT) China $0.013B 1.40
Regulus Therapeutics (RGLS) United States $0.012B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Skyline Medical (AIPT) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Aradigm (ARDM) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00